Please wait while the formulary information is being retrieved.
NORETHINDRONE ACETATE (NORETHINDRONE ACETATE)
- Abnormal uterine bleeding due to hormonal imbalance
- Endometriosis
- Secondary amenorrhea
5 mg tablet
- 1 tablet (5 mg) by oral route once daily during second half of the menstrual cycle
norethindrone acetate 5 mg tablet
- 1 tablet (5 mg) by oral route once daily during second half of the menstrual cycle
5 mg tablet
- 1 tablet (5 mg) by oral route once daily during second half of the menstrual cycle
Abnormal uterine bleeding due to hormonal imbalance
- 1 tablet (5 mg) by oral route once daily for 5 days during second half of the menstrual cycle
- 1 tablet (5 mg) by oral route once daily for 10 days during second half of the menstrual cycle
- 1 tablet (5 mg) by oral route once daily during second half of the menstrual cycle
- 2 tablets (10 mg) by oral route once daily during second half ofthe menstrual cycle
- 2 tablets (10 mg) by oral route once daily for 10 days during second half of the menstrual cycle
- 2 tablets (10 mg) by oral route once daily for 5 days during second half of the menstrual cycle
- one-half tablet (2.5 mg) by oral route once daily for 10 days during second half of the menstrual cycle
- one-half tablet (2.5 mg) by oral route once daily during second half of the menstrual cycle
- one-half tablet (2.5 mg) by oral route once daily for 5 days during second half of the menstrual cycle
Endometriosis
- 3 tablets (15 mg) by oral route once daily for 6 months
- 3 tablets (15 mg) by oral route once daily for 9 months
- 3 tablets (15 mg) by oral route once daily
Secondary amenorrhea
- 1 tablet (5 mg) by oral route once daily for 5 days during second half of the menstrual cycle
- 1 tablet (5 mg) by oral route once daily for 10 days during second half of the menstrual cycle
- 1 tablet (5 mg) by oral route once daily during second half of the menstrual cycle
- 2 tablets (10 mg) by oral route once daily during second half ofthe menstrual cycle
- 2 tablets (10 mg) by oral route once daily for 10 days during second half of the menstrual cycle
- 2 tablets (10 mg) by oral route once daily for 5 days during second half of the menstrual cycle
- one-half tablet (2.5 mg) by oral route once daily for 10 days during second half of the menstrual cycle
- one-half tablet (2.5 mg) by oral route once daily during second half of the menstrual cycle
- one-half tablet (2.5 mg) by oral route once daily for 5 days during second half of the menstrual cycle
- None
Contraindicated
- None
Severe
Moderate
- None
- Carcinoma of breast
- Disease of liver
- Porphyria
- Pregnancy
Contraindicated
- Acute myocardial infarction
- Cerebrovascular accident
- Deep venous thrombosis
- Edema
- Increased cardiovascular event risk
- Obesity
- Papilledema
- Predisposition to thrombosis
- Pulmonary thromboembolism
- Systemic lupus erythematosus
- Thromboembolic disorder
- Thrombophlebitis
- Tobacco smoker
Severe
Moderate
- Chronic heart failure
- Depression
- Diabetes mellitus
- Hyperlipidemia
- Hypertension
- Kidney disease with reduction in GFR
- Migraine
- Seizure disorder
NORETHINDRONE ACETATE (NORETHINDRONE ACETATE)
- Abnormal uterine bleeding due to hormonal imbalance
- Endometriosis
- Secondary amenorrhea
- Abdominal distension
- Abnormal vaginal bleeding
- Irregular menstrual periods
- Appetite changes
- Edema
- Fatigue
- Headache disorder
- Myalgias
- Vaginitis
- Weight loss
More Frequent
Severe
Less Severe
- None
- Dizziness
- Dyspepsia
- Hypertonia
- Irritability
- Vaginal discharge
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Anaphylaxis
- Angioedema
- Back pain
- Chest pain
- Cystitis
- Depression
- Ectopic pregnancy
- Erythema multiforme
- Erythema nodosum
- Galactorrhea not associated with childbirth
- Hepatitis
- Hypersensitivity drug reaction
- Malignant neoplasm of the ovary
- Menorrhagia
- Obstructive hyperbilirubinemia
- Optic neuritis
- Ovarian cyst
- Pancreatitis
- Pruritus of skin
- Pulmonary thromboembolism
- Retinal thrombosis
- Skin rash
- Thromboembolic disorder
- Thrombophlebitis
Less Severe
- Acne vulgaris
- Alopecia
- Amenorrhea
- Body fluid retention
- Cervical discharge
- Chloasma
- Constipation
- Drowsy
- Erosion of cervix
- Fever
- Hirsutism
- Hyperglycemia
- Insomnia
- Limb pain
- Mastalgia
- Migraine
- Nausea
- Nervousness
- Urticaria
- Weight gain
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Norethindrone
Safety and efficacy pre-menarche has not been established.
- 1 Day – 13 Years
- Safety and efficacy pre-menarche has not been established.
Norethindrone
- Severity Level:
X
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
Norethindrone
May inhibit lactation at high doses.
General | Excretion Potential | Effect on Infant | Notes |
No known risks; does not adversely affect lactation | Excreted | Not known; no or inclusive data | May inhibit lactation at high doses. |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Abnormal uterine bleeding due to hormonal imbalance | |
N92.4 | Excessive bleeding in the premenopausal period |
N92.5 | Other specified irregular menstruation |
N92.6 | Irregular menstruation, unspecified |
N93.8 | Other specified abnormal uterine and vaginal bleeding |
N93.9 | Abnormal uterine and vaginal bleeding, unspecified |
N95.0 | Postmenopausal bleeding |
Endometriosis | |
N80 | Endometriosis |
N80.0 | Endometriosis of uterus |
N80.1 | Endometriosis of ovary |
N80.2 | Endometriosis of fallopian tube |
N80.3 | Endometriosis of pelvic peritoneum |
N80.4 | Endometriosis of rectovaginal septum and vagina |
N80.5 | Endometriosis of intestine |
N80.6 | Endometriosis in cutaneous scar |
N80.8 | Other endometriosis |
N80.9 | Endometriosis, unspecified |
Secondary amenorrhea | |
N91.1 | Secondary amenorrhea |
N91.2 | Amenorrhea, unspecified |
0-9 | A-Z |
---|---|
N80 | Endometriosis |
N80.0 | Endometriosis of uterus |
N80.1 | Endometriosis of ovary |
N80.2 | Endometriosis of fallopian tube |
N80.3 | Endometriosis of pelvic peritoneum |
N80.4 | Endometriosis of rectovaginal septum and vagina |
N80.5 | Endometriosis of intestine |
N80.6 | Endometriosis in cutaneous scar |
N80.8 | Other endometriosis |
N80.9 | Endometriosis, unspecified |
N91.1 | Secondary amenorrhea |
N91.2 | Amenorrhea, unspecified |
N92.4 | Excessive bleeding in the premenopausal period |
N92.5 | Other specified irregular menstruation |
N92.6 | Irregular menstruation, unspecified |
N93.8 | Other specified abnormal uterine and vaginal bleeding |
N93.9 | Abnormal uterine and vaginal bleeding, unspecified |
N95.0 | Postmenopausal bleeding |
Formulary Reference Tool